Search results for “Bipolar illness” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 59 patents, we discovered top 27 key players by total patent application. Merck Patent GmbH, BioXcel Therapeutics, Inc., Becton Dickinson Dispensing UK Ltd. are dominant in this area. They take 37.29% of the total patent filing.
Merck Patent GmbH
Hessen, Germany
Patent: 8
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 7
Becton Dickinson Dispensing UK Ltd.
BERKSHIRE, United Kingdom
Patent: 7
Pfizer Inc.
New York, United States
Patent: 6
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 2
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 2
Taisho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 2
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
BlackThorn Therapeutics, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing BioXcel Therapeutics, Inc., Becton Dickinson Dispensing UK Ltd., Intra-Cellular Therapies, Inc. take 76.19% of patent filing during this period.
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 7
Becton Dickinson Dispensing UK Ltd.
BERKSHIRE, United Kingdom
Patent: 7
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 2
STARTUP
BlackThorn Therapeutics, Inc.
California, United States
Patent: 1
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 1
Teva Pharmaceuticals International GmbH
Switzerland
Patent: 1
PST, Inc.
Japan
Patent: 1
Wuhan University
Hubei Sheng, China
Patent: 1
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Alcediag
France
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 13 new entrants. BioXcel Therapeutics, Inc., Becton Dickinson Dispensing UK Ltd., Intra-Cellular Therapies, Inc. are the most active new entrants in this area.
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 7
Becton Dickinson Dispensing UK Ltd.
BERKSHIRE, United Kingdom
Patent: 7
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 2
STARTUP
BlackThorn Therapeutics, Inc.
California, United States
Patent: 1
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 1
PST, Inc.
Japan
Patent: 1
Wuhan University
Hubei Sheng, China
Patent: 1
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Alcediag
France
Patent: 1
Life Science Institute, Inc.
Tokyo-to, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 4 universities and scientific research institutions by total patent application. University of Miami, Tsinghua University, University of Greenwich are dominant in this area. They take 45.45% of the total patent filing.
University of Miami
United States
Patent: 1
Tsinghua University
Beijing Shi, China
Patent: 1
University of Greenwich
United Kingdom
Patent: 1
Wuhan University
Hubei Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: